Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. Author manuscript; available in PMC: 2024 Feb 9.

Published in final edited form as: J Pain Relief. 2023 Sep 8;12(Suppl 1):003.

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PMC Copyright notice

Figure 5: — PROMIS^® Pain Interference Short Form 8a T scores recorded prior to patient transfer to the operating room (preop) on POD 1, POD2, POD 7, and POD 30. No statistical differences were found between the overall scores or the scores recorded in the treatment and the placebo groups. Data recorded prior to transfer to the operating room, (baseline) on POD 1, POD 2, POD 7, and POD 30. No significant difference was reported between the treatment and the placebo group and the overall scores. Scores decrease significantly (p<0.001) on POD 1-POD30 compared to baseline (Preop). Note: () Over all () Placebo () Treatment

Inline graphic — PROMIS^® Pain Interference Short Form 8a T scores recorded prior to patient transfer to the operating room (preop) on POD 1, POD2, POD 7, and POD 30. No statistical differences were found between the overall scores or the scores recorded in the treatment and the placebo groups. Data recorded prior to transfer to the operating room, (baseline) on POD 1, POD 2, POD 7, and POD 30. No significant difference was reported between the treatment and the placebo group and the overall scores. Scores decrease significantly (p<0.001) on POD 1-POD30 compared to baseline (Preop). Note: () Over all () Placebo () Treatment